REG - BSF Enterprise PLC - 15p Warrants Amended

BSF EnterpriseAnnouncement

23/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250523:nRSW8777Ja&default-theme=true

RNS Number : 8777J  BSF Enterprise PLC  23 May 2025

 

 

London,  23 May 2025

 

BSF Enterprise PLC

 

15p Warrants Amended

 

BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in
tissue-engineered materials is pleased to announce that it has agreed to amend
the warrant instrument issued on 26 April 2022  ("Warrant Instrument")
constituting warrants to subscribe for 12,270,217 ordinary shares of one penny
each in the capital of the Company at 15p for a period of 3 years (the
"Warrants").

The Warrant Instrument has been amended to reduce the exercise price for each
of the Warrants from 15p to 7.5p and extend the exercise term by 2 years, to
expire on 17 May 2027.

The amendment will not affect any other provisions of the Warrants or any
other rights or obligations of the warrantholders.

 

Contact Information For further information, please
visit: www.bsfenterprise.com (http://www.bsfenterprise.com/)

 

For further enquiries, please visit www.bsfenterprise.com or contact:

 BSF Enterprise PLC

 Geoff Baker - Executive Director

 Che Connon - CEO & Director

 Shard Capital (Broker)
 Damon Heath                       0207 186 9000

 Isabella Pierre                   0207 186 9927

 

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge
tissue-engineered solutions, including lab-grown leather, cultivated meat, and
corneal repair technologies. By leveraging its proprietary scaffold-free
platform, BSF aims to deliver sustainable alternatives to traditional
materials and meet global demand for environmentally responsible innovations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUAPAUPAGRP